A vaping company has been blocked from selling e-cigarettes in the US.
The ruling was made by the Food and Drug Administration (FDA) after the firm, Juul Labs Inc, submitted scientific and health data regarding its nicotine products for review.
The data, gathered over almost two years, showed a “lack of sufficient evidence” that Juul’s products provided a net
benefit to public health.
Juul, together with other e-cigarette brands including British American Tobacco Plc’s Vuse and Blu, owned by Imperial Brands Plc, were given a deadline of September 2020 to submit applications to the FDA.
The health agency then had to judge whether each product helped smokers to quit.
The effectiveness of the product to encourage people to stub out their habit was weighed against potential health damage to new e-cigarette users, including teenagers, who had never smoked.
Source : skynews
